What is TrialNet?
TrialNet is a network of 18 clinical centers working with more than 200 screening sites throughout the United States, Canada, Finland, United Kingdom, Italy, Australia, and New Zealand. This network is dedicated to the study, prevention, and early treatment of type 1 diabetes. TrialNet is supported by the National Institutes of Health and major diabetes organizations. Website: www.diabetestrialnet.org
TrialNet Pathway to Prevention Study
Type 1 diabetes is a lifelong disease that occurs in both children and adults. It develops when the body attacks and destroys insulin-producing cells in the pancreas. The immune attack that leads to diabetes goes on for years before the person has symptoms. A simple screening blood test can tell us if the immune attack has begun.
Relatives of people with type 1 diabetes have about 15 times greater risk for developing the disease than people with no family history. The TrialNet Pathway to Prevention Study offers the screening blood test at no cost to family members of people with type 1 diabetes. The screening test looks for the presence of type 1 diabetes-related autoantibodies that can appear in the blood up to 10 years before type 1 diabetes develops.
- 1 to 45 years old and have a brother, sister, child, or parent with type 1 diabetes OR
- 1 to 20 years old and have a cousin, aunt, uncle, niece, nephew, half-brother, half-sister, or grandparent with type 1 diabetes.
For Medical Professionals Who Are Interested in Screening the Family Members of Your Patients and/or Becoming a TrialNet Affiliate, please click here.